Everest Medicines Ltd (1952:HK) PT Raised to HK$91.15 at Goldman Sachs
Tweet
Share
E-mailGet Alerts 1952:HK Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 21 | New: 24
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 23 | Down: 21 | New: 24
Trade Now!
Join SI Premium – FREE
Goldman Sachs analyst Ziyi Chen raised the price target on Everest Medicines Ltd (1952:HK) to HK$91.15 (from HK$75.80) while maintaining a Buy rating.
You May Also Be Interested In
- Russel Metals Inc. (RUS:CN) (RUSMF) PT Raised to Cdn$31 at RBC Capital
- Russel Metals Inc. (RUS:CN) (RUSMF) PT Raised to Cdn$31.50 at Stifel Canada
- ATS Automation Tools Systems Inc. (ATA:CN) (ATSAF) PT Raised to Cdn$35.50 at Scotiabank
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
